Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
Ketamine is a versatile medication with an emerging role for the treatment of numerous psychiatric conditions, including treatment resistant depression. Current psychiatry guidelines for its intravenous administration to treat depression recommend regular blood pressure monitoring and an aggressive...
Main Authors: | Ryan Yip, Jennifer Swainson, Atul Khullar, Roger S. McIntyre, Kevin Skoblenick |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1017504/full |
Similar Items
-
The drug liking and craving questionnaire (DLCQ) to evaluate addiction risk for ketamine and esketamine
by: Jay Wang, et al.
Published: (2022-03-01) -
Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada
by: Carson Chrenek, et al.
Published: (2024-01-01) -
Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
by: Yanling Zhou, et al.
Published: (2022-05-01) -
Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
by: Xiaofeng Lan, et al.
Published: (2022-03-01) -
Suicide prevention and ketamine: insights from computational modeling
by: Colleen E. Charlton, et al.
Published: (2023-06-01)